387.03
Vertex Pharmaceuticals Inc (VRTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
7.02%
2,964.70
|
2,770.20 | 2,912.00 | 2,771.90 | 2,645.60 |
Cost Of Revenue |
12.26%
407.50
|
363.00 | 423.40 | 392.60 | 371.90 |
Gross Profit |
6.23%
2,557.20
|
2,407.20 | 2,488.60 | 2,379.30 | 2,273.70 |
|
20.88%
1,406.10
|
1,777.10 | 1,462.60 | 1,263.00 | 5,788.40 |
Benefits Costs and Expenses |
17.56%
1,681.70
|
2,039.80 | 1,775.50 | 1,547.80 | 6,036.80 |
Costs And Expenses |
15.26%
1,813.60
|
2,140.10 | 1,886.00 | 1,655.60 | 6,160.30 |
Operating Income/Loss |
82.69%
1,151.10
|
630.10 | 1,026.00 | 1,116.30 | -3,514.70 |
Income/Loss From Continuing Operations Before Tax |
75.66%
1,283.00
|
730.40 | 1,136.50 | 1,224.10 | -3,391.20 |
Income Tax Expense/Benefit |
197.38%
250.10
|
84.10 | 223.50 | 178.70 | 202.40 |
Income/Loss From Continuing Operations After Tax |
59.82%
1,032.90
|
646.30 | 913.00 | 1,045.40 | -3,593.60 |
|
59.82%
1,032.90
|
646.30 | 913.00 | 1,045.40 | -3,593.60 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.08%
256.70
|
256.90 | -0.20 | 258.00 | 258.10 |
Diluted Average Shares |
0.23%
258.90
|
259.50 | -0.20 | 261.00 | 258.10 |
Basic Earnings Per Share |
59.52%
4.02
|
2.52 | 3.53 | 4.05 | -13.92 |
Diluted Earnings Per Share |
60.24%
3.99
|
2.49 | 3.53 | 4.01 | -13.92 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):